View Risk


Article data
Lippi (2020)
Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis
https://doi.org/10.20452/pamw.15272
https://www.ncbi.nlm.nih.gov/pubmed/32231171

Results
Comorbidities
Hypertension (Present vs. Not present)
COVID-19 (severe/critical)
Odds ratio: 2.490 (1.980-3.120) Univariate analysis

Study characteristics

China

Meta-analysis

Published studies

2893

All studies reporting data on prevalence of hypertension in adult (i.e., aged 18 years or older) laboratory-confirmed COVID-19 patients, with or without severe disease, or COVID-19 non-survivors and survivors

Aggregate data not stated

Not applicable

0


Results

COVID-19 (severe/critical)

748

COVID-19 severe diseaseâ??? (i.e., patients experiencing severe respiratory distress, needing mechanical ventilation, vital life support or intensive care unit admission)

Comorbidities

Hypertension

Not present

Present

Odds ratio

2.490 (1.980-3.120)

No

Yes

No

Not applicable


Other information

Number of cases and total number of patients not stated

Good

Go Back